Leveraging market-leading quality and consistency of Synthego modified synthetic sgRNA for CRISPR/Cas9, the arrayed libraries are delivered ready-to-screen and have comprehensive coverage of the ...

BURLINGTON, Mass., Aug. 15, 2018 /CNW/ -- MilliporeSigma today announced that the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases ...

MilliporeSigma has filed several patent applications on its proxy-CRISPR technology, and those applications are just the latest of multiple CRISPR patent filings made by the company since 2012.

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency. The research is published in the journal Science Advances.

In the study, "Targeting the SHOC2–RAS interaction in RAS-mutant cancers," published in Nature, researchers conducted a genome-wide CRISPR screen to identify genetic dependencies associated with ...